V ery preterm infants (infants born at less than 31 weeks' gestational age) are at the highest risk of developing intraventricular hemorrhage (IVH) of prematurity. Approximately 15%-20% of very preterm infants develop IVH, 5 which is typically diagnosed using bedside cranial ultrasound. The severity of the hemorrhage is usually described using the Papile grading system 10 as Grades 1-4. 6, 20 Current literature suggests that approximately 33% of infants with IVH of prematurity will develop posthemorrhagic ventricular dilation, defined radiographically as having ventricles that are larger than the 97th percentile for the estimated gestational age. 4, 7 A recent review of the literature found that 10% of patients who develop any grade of IVH and 20% of patients who develop severe IVH develop posthemorrhagic hydrocephalus (PHH), defined as ventricular dilation and symptoms and signs of raised intracranial pressure following a diagnosis of IVH.
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Temporal trends of intraventricular hemorrhage of prematurity in Nova Scotia from 1993 to 2012
Health and Human Development Neonatal Research Network to provide a multicenter snapshot based on the experience of select academic centers. Therefore, there could be significant selection bias impacting the validity of these epidemiology reports.
The objective of this study was to accurately describe the trends in incidence of IVH and subsequent PHH/shunt surgery over time, by studying a population-based cohort of very preterm (gestational age ≥ 20 and ≤ 30 weeks) infants born to residents of Nova Scotia from January 1, 1993, to December 31, 2012, using a prospective database with minimal selection bias.
methods
All very preterm (≤ 30 completed weeks' gestational age) infants born to residents of Nova Scotia from January 1, 1993, onward were included in a comprehensive database. Inclusion criteria for this study included the following: born to a resident of Nova Scotia between January 1, 1993, and December 31, 2012, gestational age of ≤ 30 weeks but ≥ 20 weeks, and successfully resuscitated at birth. Exclusion criteria included: missing information about IVH status (which only occurred when an infant died before the initial 3-day postnatal screening ultrasound and also no autopsy was performed).
Dr. Michael Vincer, who has been in charge of this database and the perinatal follow-up program for the duration of the study period, actively tracks all preterm births in Nova Scotia. The majority of these patients are managed at our center. In addition, Dr. Vincer regularly visits the only 2 other regional neonatal units that manage preterm infants of Nova Scotian mothers (in Moncton, New Brunswick, and in Sydney, Nova Scotia) to collect data on the preterm infants treated at these sites. Preterm infants managed outside of Moncton, Sydney, or Halifax (for example, one born to a Nova Scotian mother while she was traveling elsewhere on vacation) would also be routinely referred to the perinatal follow-up program at the IWK Health Centre in Halifax by their pediatrician or family doctor once the infant and mother returned to Nova Scotia.
The imaging screening protocol has remained largely unchanged since 1993 in Nova Scotia. Very preterm infants universally undergo cranial ultrasonography screening examinations within 3 days of birth, at 2 weeks, at 6 weeks, and again at term. The method of ultrasound screening did change slightly starting in 2010 to include examining the brain through multiple approaches in addition to through the anterior fontanel. Furthermore, since 2010, some infants have been examined with MRI brain instead of an ultrasound examination at term.
The resuscitation protocol has undergone few changes over time. A formalized neonatal resuscitation program was first initiated approximately 20 years ago. In 1999, a practice of wrapping babies in polyethylene occlusive wrap 19 was started, and this became standard practice in 2000. In the past 10 years, there has been a reduction in oxygen use in the delivery room. Also, 15 years ago, respiratory therapists were added to the resuscitation team.
PHH was defined as the presence of ventricles larger than the 97th percentile for estimated gestational age in infants who also had symptoms and signs of raised intracranial pressure (enlarging head circumference, splaying of the cranial sutures, and a full fontanel) following a diagnosis of IVH. Infants with PHH received a permanent shunt if they reached a weight of 2 kg and continued to have a diagnosis of PHH. Ventricular access devices (VADs), or watchful waiting, were used to bridge the gap in between diagnosis of PHH and weight of 2 kg, at the discretion of the surgeon. Infants whose ventricle dimensions and clinical status stabilized or improved by the time they reached 2 kg in weight did not receive a permanent shunt.
The numbers of infants who were successfully resuscitated at birth, who were diagnosed with IVH, who developed PHH, and who were treated with a shunt for CSF diversion by their final follow-up between 2 and 3 years of age, were extracted from the database (Fig. 1) . The number of infants who were treated with a VAD was also determined, as was the percentage of infants who were lost to final follow-up after discharge from the neonatal intensive care unit (NICU).
The incidence of IVH (by Papile grade 4 ) and of PHH, VAD use, and shunt surgery in all very preterm infants born to residents of Nova Scotia from January 1, 1993, to December 31, 2012, was calculated for this cohort. A chi-square test for trend was used to assess for changing incidence of IVH, PHH, VAD use, and shunt surgery over time, with time broken down into 5-year epochs.
Odds ratios for IVH were calculated and assessed for significance using univariate logistic regression for several perinatal, infant, and maternal variables, including use of antenatal steroids, birth weight, cardiopulmonary resuscitation, inotrope usage, gestational age, infant respiratory distress syndrome, cesarean section, maternal age, maternal weight, maternal height, infant sex, surfactant use, use of high-flow oscillatory ventilation, ventilation use, infant death in the first 7 days, neonatal death, gestational hypertension, maternal fever during labor, suspected intrauterine growth restriction on ultrasonography, birth asphyxia, necrotizing enterocolitis, overall chance of resuscitation at birth, intrapartum magnesium sulfate use, twin pregnancy, nitric oxide use, use of a paralyzing agent, phototherapy, and cystic periventricular leukomalacia. Univariate linear regression was used to assess for significant associations between each of these variables and time (in 5-year epochs).
Multivariate logistic regression was used to assess for a significant association between IVH and time, as well as Grade 3 or 4 IVH and time, controlling first for death in the first 7 days, and second for perinatal, infant, and maternal variables that were significantly associated with both IVH and time and that were clinically determined to occur primarily before the diagnosis of IVH.
Multivariate logistic regression was also used to determine whether hydrocephalus and CSF shunting following a Grade 3 or 4 IVH were significantly associated with time, when controlling for mortality.
All data analysis was carried out using STATA 11.2 (StataCorp LP). Results were considered statistically significant if they had a p value < 0.05. Ethics approval for this research was obtained from the IWK Health Centre Research Ethics Board.
results intraventricular hemorrhage
A total of 1502 very preterm infants (≥ 20 and ≤ 30 weeks gestational age) were born to residents of Nova Scotia from January 1, 1993, to December 31, 2012, and of these, 1352 (90%) infants were successfully resuscitated. Of these, 18 died within the first 13 hours of life before receiving a screening ultrasound and without receiving an autopsy, leaving a total of 1334 infants. Of these, 407 (31%) infants received a diagnosis of IVH and 170 (13%), 88 (7%), 62 (5%), and 87 (7%) a diagnosis of IVH Grade 1, 2, 3, and 4, respectively. Thirty infants (2%) were lost to follow-up after discharge from the NICU (Fig. 1) .
The percentage of successfully resuscitated very preterm infants with IVH of any grade has not changed sig- (Fig. 2) .
A list of various infant, maternal, and management variables, their associations with IVH, and their change in incidence over time can be found in Table 1 . Note that, in particular, the percentage of very preterm infants who were successfully resuscitated has not changed significantly over time (p = 0.279), and the gestational age of successfully resuscitated very preterm infants was not significantly different between the first 5 years and the last 5 years of this study (p = 0.404). On the other hand, both 7-day and 28-day mortality in successfully resuscitated very preterm infants have significantly decreased over time (p < 0.001, p < 0.001). Multivariable logistic regression analysis looking at the association between IVH and time, controlling for death in the first 7 days after birth, resulted in a significant association between both IVH of any grade and time (OR 1.14, p = 0.011) and Grade 3 or 4 IVH and time (OR 1.36, p < 0.001). A number of other potential protective factors and risk factors for IVH have also changed significantly over time (Table 1) .
From Table 1 , the variables that showed a statistically significant association with both IVH and time and that were clinically determined to potentially occur before IVH diagnosis were antenatal corticosteroid use, birth weight, cardiopulmonary resuscitation (CPR), dobutamine use, dopamine use, surfactant use, high-flow oscillatory ventilation use, maternal fever during labor, suspected intrauterine growth restriction on ultrasonography, birth 
hydrocephalus and Shunt Surgery
Of successfully resuscitated infants born between January 1, 1993, and December 31, 2012, 0 (0%) of 170 infants with Grade 1 IVH, 0 (0%) of 88 infants with Grade 2 IVH, 15 (24%) of 62 infants with Grade 3 IVH, and 32 (37%) of 87 infants with Grade 4 IVH, compared with 0 (0%) of 927 infants without IVH, were diagnosed with hydrocephalus (Fig. 3) . The percentage of very preterm infants with Grade 3 or 4 IVH who were diagnosed with hydrocephalus has increased over time (p = 0.001), from 16% (5 of 31 infants) during 1993-1997 to 48% (24 of 50) during 2008-2012 (Fig. 4) . On multivariate logistic regression analysis, controlling for mortality, hydrocephalus remains significantly associated with time (OR 1.64, p = 0.005).
Also, 0 (0%) of 170 infants with Grade 1 IVH, 0 (0%) of 88 infants with Grade 2 IVH , 7 (11%) of 62 with Grade 3 IVH, and 21 (24%) of 87 with Grade 4 IVH, compared with 0 (%) of 927 without IVH, were treated with a shunt for hydrocephalus (Fig. 3) . The percentage of very preterm infants with Grade 3 or 4 IVH who were treated with a shunt has also increased over time (p = 0.011), from 10% (3 of 31) during 1993-1997 to 30% (15 of 50) during 2008-2012 (Fig. 4) . On multivariate logistic regression analysis, controlling for mortality, shunting remains significantly associated with time (OR 1.51, p = 0.049). The percentage of very preterm infants with hydrocephalus who were treated with a shunt (28/47, 60%) has not changed over time (p = 0.813) (Fig. 5) .
Furthermore, 2 (13%) of 15 and 8 (21%) of 32 infants with hydrocephalus following Grade 3 and Grade 4 IVH, respectively, were treated with a VAD over the study period; 9 of 10 infants with a VAD went on to need a permanent shunt, and 1 infant with Grade 3 IVH improved and did not require a shunt. Of the other 37 infants with PHH who were not treated with a VAD (13 of 
discussion
This population-based study confirms that IVH is a common diagnosis in very preterm infants, with 31% of successfully resuscitated very preterm infants developing IVH of any grade, and 11% developing IVH Grade 3 or 4. In addition, in Nova Scotia, the incidence of IVH Grades 3 or 4 appears to be significantly increasing in very preterm infants over time. This observation is in contrast with other studies that have reported a stable 2, 8 or decreasing 12, 13, 16 incidence of IVH of prematurity, though some centers report an increasing incidence. 11 None of these studies are population based and are therefore subject to referral bias. Furthermore, some represent more historical time periods, 2, 12, 16 and are therefore not directly comparable to this study. The reasons for the increasing incidence of IVH of prematurity in the Nova Scotia population are uncertain. Importantly, the increasing incidence is not explained by changes in diagnostic criteria (which have not changed since 1993 and continue to be based on the Papile grading system). Additionally, the imaging screening protocol has remained unchanged since 1993 in Nova Scotia. Furthermore, although the method of screening changed slightly starting in 2010 to include examining the brain via ultrasonography through multiple approaches in addition to through the anterior fontanel, as well as by occasionally replacing the ultrasonographic examination performed at term with MRI since 2010, this is unlikely to have significantly impacted incidence proportions of Grade 3 and 4 IVHs, and so does not explain the increasing incidence over time.
Other factors were considered as well. Gestational age and proportion of very preterm infants who were successfully resuscitated at birth do not appear to be changing over time and so cannot explain the increasing incidence of Grade 3 or 4 IVH in this cohort. On the other hand, neonatal mortality appears to have decreased over time. It was considered that perhaps more infants were surviving to be diagnosed with IVH than before; however, the association between Grade 3 or 4 IVH and time remains significant when controlling for early mortality in the first 7 days after birth. Furthermore, IVH of any grade becomes significantly associated with time as well, which implies that the association between IVH and time is not solely due to improved survival.
Several variables that are risk factors for IVH 14, 15, 18 are increasing in incidence over time in Nova Scotia, which may help explain the increasing IVH incidence. These include infant CPR and inotrope use. Other risk factors are decreasing, such as maternal fever during labor, and other protective factors are increasing in incidence over time, such as antenatal steroid use. From the multivariate logistic regression analysis, it seems that the increasing incidence in IVH could be at least partially explained by the increasing use of CPR and ionotropes and by improved survival in the 1st week after birth. The increase over time in these risk factors could be overriding the increase over time in protective antenatal steroid use and decrease over time in maternal fever during labor, leading to increasing incidence of IVH of prematurity. Further research into the cause of the increasing incidence of IVH is essential, as IVH comes with significant risk of morbidity and mortality. Interestingly, this study demonstrated that the lower grades of IVH (Grades 1 and 2) are associated with a very low risk (no observed cases in this cohort) of developing PHH and requiring shunt surgery, in contrast to previous reports, which showed risks as high as a 5% and 20% for developing PHH for IVH Grade 1 and Grade 2, respectively. 9, 17 This could be due to referral bias in other studies, as they are not population based. The centers reporting IVH and PHH risks in previously published studies may have been referred only the sickest IVH patients, which may have suggested a disproportionately high risk of hydrocephalus in Grade 2 IVH infants. Our center is referred all infants with IVH, and hence referral bias is unlikely in the present study.
The incidence of both PHH and shunt placement in the group of very preterm infants with Grade 3 or 4 IVH has been increasing over time as well. There has been no significant change over time in the proportion of infants with PHH who have received a shunt, so the increase in shunt placement over time appears to be due to the increase in PHH risk over time and not due to change in indications for shunt placement over time in infants with PHH. This experience is in contrast to that of other centers that have reported a decreased 1 or stable 8 risk of PHH in infants with severe IVH. Note must be made here that the definition of PHH used by this database has not changed since 1993, so the increasing incidence of hydrocephalus in severe IVH cannot be explained by any such change. Given increasing survival over time to the estimated delivery date, perhaps more infants with IVH are surviving to be diagnosed with clinical hydrocephalus. However, the association between PHH and time and between shunting and time remains significant even when controlling for improved survival, suggesting that other factors are likely at play. Further research is needed to determine what these factors might be.
This study is limited by the censoring of infants with a gestational age of 31 weeks or more, and so the results of this analysis are only applicable to infants born at less than 31 weeks' gestational age. However, the risk of IVH in infants of 31 weeks' gestational age or older is much lower than in infants born at an earlier gestational age, 13 and so these study results are likely reflective of the majority of IVH cases in infants born to residents of Nova Scotia during the study period.
The strengths of this study include the extensive efforts made to ensure that every very preterm infant born to a resident of Nova Scotia during the study period was included in this database for the duration of their NICU admission, including infants born at all hospitals that provided NICU care to Nova Scotia residents. All of these infants/families were then offered the opportunity to remain included in the Perinatal Follow-Up Program and database after discharge from the hospital until final follow-up at between 2 and 3 years of age, and the loss-to-follow-up risk was only 2%. Consequently, there is a very low risk of selection bias, which increases the validity of this population-based study and makes the results generalizable to other populations with similar demographics and NICU management protocols.
conclusions
In conclusion, IVH, PHH, and shunt treatment are common in very preterm infants, and their incidence has been increasing over time. The reasons for this are unclear, although it may be partially due to improving survival and increasing incidence of various risk factors for IVH. The trend is worrisome, and further study is needed to identify preventable and treatable causal factors. 
